KF 20274

Drug Profile

KF 20274

Latest Information Update: 28 May 2001

Price : $50

At a glance

  • Originator Kyowa Hakko
  • Class Imidazoles; Laxatives; Neuroprotectants; Polycyclic bridged compounds; Small molecules
  • Mechanism of Action Adenosine A1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Constipation

Most Recent Events

  • 28 May 2001 Discontinued-Preclinical for Constipation in Japan (PO)
  • 03 Nov 1998 No-Development-Reported for Constipation in Japan (PO)
  • 26 Feb 1996 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top